DK125555B - Fremgangsmåde til fremstilling af 1,2-dihydro-5-aryl-5H- eller 1,2-dihydro-5-aryl-3H-1,4-benzodiazepin-4-oxider, 4-deoxyderivater deraf eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af 1,2-dihydro-5-aryl-5H- eller 1,2-dihydro-5-aryl-3H-1,4-benzodiazepin-4-oxider, 4-deoxyderivater deraf eller syreadditionssalte deraf.

Info

Publication number
DK125555B
DK125555B DK624065AA DK624065A DK125555B DK 125555 B DK125555 B DK 125555B DK 624065A A DK624065A A DK 624065AA DK 624065 A DK624065 A DK 624065A DK 125555 B DK125555 B DK 125555B
Authority
DK
Denmark
Prior art keywords
dihydro
aryl
benzodiazepine
oxides
preparation
Prior art date
Application number
DK624065AA
Other languages
English (en)
Inventor
G Field
L Sternbach
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US415793A external-priority patent/US3398139A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to DK301070A priority Critical patent/DK133155C/da
Publication of DK125555B publication Critical patent/DK125555B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C17/00—Surface treatment of glass, not in the form of fibres or filaments, by coating
    • C03C17/34—Surface treatment of glass, not in the form of fibres or filaments, by coating with at least two coatings having different compositions
    • C03C17/36—Surface treatment of glass, not in the form of fibres or filaments, by coating with at least two coatings having different compositions at least one coating being a metal
    • C03C17/3602—Surface treatment of glass, not in the form of fibres or filaments, by coating with at least two coatings having different compositions at least one coating being a metal the metal being present as a layer
    • C03C17/3668—Surface treatment of glass, not in the form of fibres or filaments, by coating with at least two coatings having different compositions at least one coating being a metal the metal being present as a layer the multilayer coating having electrical properties
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K5/00—Heat-transfer, heat-exchange or heat-storage materials, e.g. refrigerants; Materials for the production of heat or cold by chemical reactions other than by combustion
    • C09K5/08—Materials not undergoing a change of physical state when used
DK624065AA 1964-04-10 1965-12-03 Fremgangsmåde til fremstilling af 1,2-dihydro-5-aryl-5H- eller 1,2-dihydro-5-aryl-3H-1,4-benzodiazepin-4-oxider, 4-deoxyderivater deraf eller syreadditionssalte deraf. DK125555B (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK301070A DK133155C (da) 1964-04-10 1970-06-10 Quinazolinderivater og syreadditionssalte deraf til anvendelse som mellemprodukter ved fremstilling af benzodiazepinderivater

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US35891964A 1964-04-10 1964-04-10
US40019364A 1964-09-29 1964-09-29
US415793A US3398139A (en) 1964-04-10 1964-12-03 Process for preparing 2-amino-benzodiazepines
US73547668A 1968-04-09 1968-04-09
US73548468A 1968-04-09 1968-04-09
US73547868A 1968-04-09 1968-04-09
US73547968A 1968-04-09 1968-04-09
US73547568A 1968-04-09 1968-04-09

Publications (1)

Publication Number Publication Date
DK125555B true DK125555B (da) 1973-03-05

Family

ID=27575413

Family Applications (7)

Application Number Title Priority Date Filing Date
DK182565AA DK121123B (da) 1964-04-10 1965-04-09 Fremgangsmåde til fremstilling af 1,2-dihydro-4-phenyl-quinazolin-3-oxider eller syradditionssalte deraf.
DK492765AA DK120752B (da) 1964-04-10 1965-09-24 Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK621565AA DK117229B (da) 1964-04-10 1965-12-02 Fremgangsmåde til fremstilling af 2-substituerede 4-aryl-quinazolin-3-oxider.
DK624065AA DK125555B (da) 1964-04-10 1965-12-03 Fremgangsmåde til fremstilling af 1,2-dihydro-5-aryl-5H- eller 1,2-dihydro-5-aryl-3H-1,4-benzodiazepin-4-oxider, 4-deoxyderivater deraf eller syreadditionssalte deraf.
DK163566AA DK115108B (da) 1964-04-10 1966-03-29 Fremgangsmåde til fremstilling af 2-amino-benzophenon-β-oximer.
DK163466AA DK115851B (da) 1964-04-10 1966-03-29 Fremgangsmåde til fremstilling af 1,2-dihydro-4-aryl-quinazoliner eller syreadditionssalte deraf.
DK301070A DK133155C (da) 1964-04-10 1970-06-10 Quinazolinderivater og syreadditionssalte deraf til anvendelse som mellemprodukter ved fremstilling af benzodiazepinderivater

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DK182565AA DK121123B (da) 1964-04-10 1965-04-09 Fremgangsmåde til fremstilling af 1,2-dihydro-4-phenyl-quinazolin-3-oxider eller syradditionssalte deraf.
DK492765AA DK120752B (da) 1964-04-10 1965-09-24 Fremgangsmåde til fremstilling af 5-aryl-3H-1,4-benzodiazepin-4-oxider.
DK621565AA DK117229B (da) 1964-04-10 1965-12-02 Fremgangsmåde til fremstilling af 2-substituerede 4-aryl-quinazolin-3-oxider.

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK163566AA DK115108B (da) 1964-04-10 1966-03-29 Fremgangsmåde til fremstilling af 2-amino-benzophenon-β-oximer.
DK163466AA DK115851B (da) 1964-04-10 1966-03-29 Fremgangsmåde til fremstilling af 1,2-dihydro-4-aryl-quinazoliner eller syreadditionssalte deraf.
DK301070A DK133155C (da) 1964-04-10 1970-06-10 Quinazolinderivater og syreadditionssalte deraf til anvendelse som mellemprodukter ved fremstilling af benzodiazepinderivater

Country Status (14)

Country Link
US (5) US3503975A (da)
BE (6) BE662354A (da)
BR (5) BR6568738D0 (da)
CH (10) CH507215A (da)
DE (8) DE1545942A1 (da)
DK (7) DK121123B (da)
FI (1) FI46965C (da)
FR (8) FR1459759A (da)
GB (10) GB1082163A (da)
IL (5) IL23270A (da)
MY (2) MY6800112A (da)
NL (8) NL6504628A (da)
NO (4) NO122653B (da)
SE (9) SE338779B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238610A (en) * 1979-12-20 1980-12-09 Hoffmann-La Roche Inc. Intermediates for the production of imidazobenzodiazepines
CA1157855A (en) * 1980-07-31 1983-11-29 Albert E. Fischli Benzodiazepine derivatives
US4472435A (en) * 1980-07-31 1984-09-18 Hoffman-La Roche Inc. Benzophenone derivatives useful in treating heart failure
US5326765A (en) * 1990-02-14 1994-07-05 Ortho Pharmaceutical Corporation 2,2,4-trialkyl-1,2-dihydroquinazoline-3-oxides
AU2002354054A1 (en) * 2002-10-18 2004-05-04 Ono Pharmaceutical Co., Ltd. Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
US7086167B2 (en) * 2004-04-16 2006-08-08 Empire Level Mfg. Corp. Overmolded vial for use with a level
CN115108968A (zh) * 2021-03-23 2022-09-27 上药康丽（常州）药业有限公司 一种3-(4-溴苯基)-哌啶的生产方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138586A (en) * 1964-06-23 Z-cycloalkylamino derivatives of
US3179656A (en) * 1965-04-20 Azepine x-oxidss
US3311612A (en) * 1967-03-28 Process for preparing
US3267110A (en) * 1960-06-03 1966-08-16 Smith Kline French Lab Trifluoromethyl substituted o-aminophenyl ketones
US3389176A (en) * 1961-09-11 1968-06-18 Hoffmann La Roche 2-aminophenyl-cycloalkyl-ketoximes
US3321467A (en) * 1963-11-27 1967-05-23 Hoffmann La Roche 3-halo-1, 4-benzodiazepin-2-ones
US3398139A (en) * 1964-04-10 1968-08-20 Hoffmann La Roche Process for preparing 2-amino-benzodiazepines

Also Published As

Publication number Publication date
DK133155C (da) 1976-09-06
BE673107A (da) 1966-06-01
NL6802319A (da) 1968-04-25
GB1082444A (en) 1967-09-06
DK133155B (da) 1976-03-29
MY6800112A (en) 1968-12-31
DE1545942A1 (de) 1969-12-18
BE670133A (da) 1966-03-28
FR1482841A (fr) 1967-06-02
CH498844A (de) 1970-11-15
BR6575397D0 (pt) 1973-09-06
NO122653B (da) 1971-07-26
SE320080B (da) 1970-02-02
NL6512614A (da) 1966-03-30
GB1124247A (en) 1968-08-21
US3485823A (en) 1969-12-23
IL23270A (en) 1969-02-27
DE1545964A1 (de) 1970-01-22
CH507259A (de) 1971-05-15
FI46965C (fi) 1973-08-10
NL7006996A (da) 1970-09-23
FR4904M (da) 1967-04-17
US3523972A (en) 1970-08-11
NL131734C (da) 1971-06-15
GB1124245A (en) 1968-08-21
GB1124244A (en) 1968-08-21
GB1082163A (en) 1967-09-06
DK121123B (da) 1971-09-13
GB1124248A (en) 1968-08-21
SE317384B (da) 1969-11-17
SE350756B (da) 1972-11-06
DE1695193A1 (de) 1971-04-08
CH469008A (de) 1969-02-28
NO121951B (da) 1971-05-03
BR6573523D0 (pt) 1973-09-11
CH469722A (de) 1969-03-15
FR1459759A (fr) 1966-06-17
BR6575398D0 (pt) 1973-09-06
GB1124246A (en) 1968-08-21
NO120476B (da) 1970-10-26
US3503975A (en) 1970-03-31
BR6575394D0 (pt) 1973-09-06
GB1082165A (en) 1967-09-06
NL7006995A (da) 1970-09-23
DK115851B (da) 1969-11-17
SE345458B (da) 1972-05-29
SE345455B (da) 1972-05-29
FR1476612A (fr) 1967-04-14
CH470399A (de) 1969-03-31
NL6504628A (da) 1965-10-11
IL24658A (en) 1970-01-29
US3594364A (en) 1971-07-20
GB1082164A (en) 1967-09-06
FR1476609A (fr) 1967-04-14
DE1545975A1 (de) 1969-11-20
BE662354A (da) 1965-10-11
SE320081B (da) 1970-02-02
DE1618518A1 (de) 1971-03-04
DK120752B (da) 1971-07-12
IL24703A (en) 1969-11-12
DE1545972A1 (de) 1970-07-02
DE1545974A1 (de) 1969-12-11
FR1447832A (fr) 1966-07-29
GB1124829A (en) 1968-08-21
SE318281B (da) 1969-12-08
DE1795500A1 (de) 1972-02-03
IL24258A (en) 1969-05-28
CH470401A (de) 1969-03-31
SE338779B (da) 1971-09-20
BE673109A (da) 1966-06-01
NL6515759A (da) 1966-06-06
BE673108A (da) 1966-06-01
NL6515499A (da) 1966-06-06
CH487908A (de) 1970-03-31
NL6515758A (da) 1966-06-06
FI46965B (da) 1973-05-02
CH462177A (de) 1968-09-15
DK115108B (da) 1969-09-08
IL24659A (en) 1970-01-29
CH462832A (de) 1968-09-30
FR4621M (da) 1967-01-02
DK117229B (da) 1970-03-31
CH507215A (de) 1971-05-15
US3485841A (en) 1969-12-23
NO121607B (da) 1971-03-22
BR6568738D0 (pt) 1973-08-07
BE673106A (da) 1966-06-01
FR1482840A (fr) 1967-06-02
SE318282B (da) 1969-12-08
MY6900183A (en) 1969-12-31

Similar Documents

Publication Publication Date Title
DK113295B (da) Fremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.
DK130070B (da) Analogifremgangsmåde til fremstilling af 3,4-dihydroxyphenylalkanolaminer eller syreadditionssalte deraf.
DK124404B (da) Fremgangsmåde til fremstilling af 2-arylamino-1,3-diazacycloalkener-(2) eller syreadditionssalte deraf.
DK107288C (da) Fremgangsmåde til fremstilling af arylalkylaminoguanidiner eller syreadditionssalte deraf.
DK114618B (da) Fremgangsmåde til fremstilling af α-dithiosemicarbazoner eller syreadditionssalte deraf.
DK126592B (da) Analogifremgangsmåde til fremstilling af substituerede 2-anilinopyridiner eller syreadditionssalte deraf.
DK125555B (da) Fremgangsmåde til fremstilling af 1,2-dihydro-5-aryl-5H- eller 1,2-dihydro-5-aryl-3H-1,4-benzodiazepin-4-oxider, 4-deoxyderivater deraf eller syreadditionssalte deraf.
DK109805C (da) Fremgangsmåde til fremstilling af basisk substituerede 2-oxobenzimidazoliner eller syreadditionssalte deraf.
DK115110B (da) Fremgangsmåde til fremstilling af anticholeterolemeisk sktive 25-aza-19-nor-1,3,5(10)-cholestatriener eller syreadditionssalte deraf.
DK121367B (da) Analogifremgangsmåde til fremstilling af 3,3-difenylallylaminderivater eller syreadditionssalte deraf.
DK135231B (da) Analogifremgangsmåde til fremstilling af basisk substituerede 2,3-cis, trans-diphenylcyclopropanderivater eller syreadditionssalte deraf.
DK122327B (da) Analogifremgangsmåde til fremstilling af N-alkyllincomycin D-forbindelser eller syreadditionssalte deraf.
DK118663B (da) Analogifremgangsmåde til fremstilling af basisk substituerede derivater af 5,6-dihydro-dibenz-[b,e]-azepin-6, 11-dion-11-oxim eller syreadditionssalte deraf.
DK118657B (da) Analogifremgangsmåde til fremstilling af 3',4',5'-trimethoxy-3-aminoacrylophenoner eller syreadditionssalte deraf.
DK115703B (da) Fremgangsmåde til fremstilling af N-alkylpolyhydrobenzazepinopyridoindoler eller syreadditionssalte deraf.
DK118668B (da) Fremgangsmåde til fremstilling af tetrahydro-1,3,5-thiadiazin-2-thioner eller syreadditionssalte deraf.
DK112524B (da) Fremgangsmåde til fremstilling af N-aralkylpiperidin-derivater eller syreadditionssalte deraf.
DK124614B (da) Fremgangsmåde til fremstilling af 3-(3-piperidino- eller morpholinopropionyl)-5-phenylisoxazolderivater eller syreadditionssalte deraf.
DK121375B (da) Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf.
DK119705B (da) Fremgangsmåde til fremstilling af 4,5-disubstituerede 2-alkyl-3-hydroxy-pyridiner eller syreadditionssalte deraf.
DK125552B (da) Fremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolin-2-carboxamidiner eller syreadditionssalte deraf.
DK107227C (da) Fremgangsmåde til fremstilling af 3,8-diazabicyklooktanderivater af fentiaziner, eller syreadditionssalte deraf.
DK115994B (da) Fremgangsmåde til fremstilling af (3,5-diamino-6-halogenpyrazinoyl)-guanidin- eller (3,5-diamino-6-halogenpyrazinamido)-guanidinforbindelser eller syreadditionssalte deraf.
DK113147B (da) Fremgangsmåde til fremstilling af 1,4-benzodioxanderivater eller syreadditionssalte heraf.
DK108363C (da) Fremgangsmåde til fremstilling af 9,10-dihydro-anthracenderivater eller syreadditionssalte deraf.